Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis.
Hao ChenNobuyuki HoritaKentaro ItoHideyuki NagakuraYu HaraNobuaki KobayashMasaki YamamotoMakoto KudoTakeshi KanekoPublished in: Therapeutic advances in medical oncology (2020)
Patients treated with carboplatin+amrubicin, carboplatin+etoposide+atezolizumab, CBDCA/CDDP+etoposide+durvalumab, and platinum+irinotecan showed better HRos than those treated with platinum+etoposide, one of the standard regimens.